Table 2.
Parents report of ADHD core symptoms (attention, hyperactivity, total score) regarding the treatments (NF, MED, combined)
| |
Pre treatment |
Post treatment |
Pre-Post change (T1-T2)1 |
|
Treatment effect2 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barkley rating scores | N | Mean | 95 % CI | N | Mean | 95 % CI | N | Mean3 | 95 % CI | Effect size4 | p-unadj.5 | p-adj.6 | p-uadj.5 | p-adj.6 |
| Total |
< .001 |
0,310 |
0.173 |
0,228 |
||||||||||
| Medication |
29 |
34,5 |
(30.6, 38.5) |
22 |
27,8 |
(24.0, 31.6) |
22 |
7.9 |
(4.5, 11.4) |
|
|
|
|
|
| Neurofeedback + Medication |
24 |
32,6 |
(28.6, 36.6) |
22 |
23,7 |
(19.8, 27.6) |
22 |
8,6 |
(5.0, 12.2) |
1.76 |
|
|
|
|
| Neurofeedback |
23 |
37 |
(33.9, 40.0) |
19 |
26,7 |
(23.4, 30.1) |
19 |
10,7 |
(7.6, 13.8) |
2.25 |
|
|
|
|
| Attention |
< .001 |
0,738 |
0,098 |
0,139 |
||||||||||
| Medication |
29 |
15,9 |
(13.8, 18.0) |
22 |
15,2 |
(13.2, 17.2) |
22 |
1,5 |
(-0.3, 3.3) |
0.70 |
|
|
|
|
| Neurofeedback + Medication |
24 |
15,9 |
(13.9, 18.0) |
22 |
14,5 |
(12.0, 17.2) |
22 |
1,1 |
(-0.7, 3.0) |
0.46 |
|
|
|
|
| Neurofeedback |
23 |
19,2 |
(17.2, 21.1) |
19 |
16,6 |
(14.5, 18.7) |
19 |
3,1 |
(1.6, 4.5) |
2.08 |
|
|
|
|
| Hyperactivity |
< .001 |
0,077 |
0,101 |
0,186 |
||||||||||
| Medication |
29 |
18,7 |
(16.3, 21.0) |
22 |
12,5 |
(10.2, 14.4) |
22 |
6,5 |
(4.3, 8.6) |
2.45 |
|
|
|
|
| Neurofeedback + Medication |
24 |
16,7 |
(14.3, 19.0) |
22 |
9,1 |
(6.8, 11.4) |
22 |
7,5 |
(4.9, 10.0) |
1,75 |
|
|
|
|
| Neurofeedback | 23 | 17,8 | (15.9, 19.6) | 19 | 10,1 | (8.0, 12.2) | 19 | 7,6 | (5.6, 9.6) | 2.88 | ||||
1 Tests for within-subject-contrast in the General linear modell (GLM). 2 Between-groups-effect in the GLM. 3 Mean of the differences, i.e. excluding drop outs at one missing point. 4 Effect size measure δRM (ref Morris). 5 Unadjusted model. 6 Model adjusted for age and sex.